After TADS, can we measure up, catch up, and ante up?

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 45, Issue 12, 2006, Pages 1456-1460

  Jensen, Peter S ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADOLESCENT DISEASE; BEHAVIOR THERAPY; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITIVE THERAPY; COMPARATIVE STUDY; HUMAN; MAJOR DEPRESSION; MONOTHERAPY; NOTE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FLUOXETINE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS;

EID: 33845407507     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000237712.81378.9d     Document Type: Note

References (23)

1. Asarnow JR, Jaycox LH, Duan N et al. (2005), Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial. JAMA 293:311-319
2. Centers for Disease Control and Prevention (2004), Unintentional injuries, violence, and the health of young people. Available at: http://www.cdc.gov/HealthyYouth/injury/pdf/facts.pdf. Accessed August 1, 2006
3. Cheung A, Zuckerbrot R, Jensen PS, Laraque D, Stein REK, GLAD-PC Steering Group (in press), Guidelines for adolescent depression in primary care (GLAD-PC). Pediatrics
4. Chorpita BF, Barlow DH, Albano AM, Daleiden EL (1998), Methodological strategies in child clinical trials: advancing the efficacy and effectiveness of psychosocial treatments. J Abnorm Child Psychol 26:7-16
5. Cross-National Collaborative Group (1993), The changing rate of major depression: cross-national comparisons. JAMA 268:3098-3105
6. Curry J, Rohde P, Simon A et al. (2006), Predictors and moderators of acute outcome in the Treatment for Adolescents With Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 45:1427-1439
7. Emslie G, Kratochvil C, Vitiello B et al. (2006), Treatment for Adolescents With Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry 45:1440-1455
8. Hinshaw SP (2005), The stigmatization of mental illness in children and parents: Developmental issues, family concerns, and research needs. J Child Psychol Psychiatry 46:714-734
9. Jensen PS, Weersing R, Eaton-Hoagwood K, Goldman E (2005), What is the evidence for evidence-based treatments? A hard look at our soft underbelly. Ment Health Serv 7:53-74
10. Kazdin AE (2004), Evidence-based treatments: challenges and priorities for practice and research. Child Adolesc Psychiatr Clin N Am 13:923-940
11. Kennard B, Silva S, Vitiello B et al. (2006), Remission and residual symptoms after short-term treatment in the Treatment of Adolescents With Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 45:1404-1411
12. Kessler RC, Avenevoli S, Merikangas K (2001), Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry 49: 1002-1014
13. Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG (1994), Sex and depression in the National Comorbidity Survey. II: Cohort effects. J Affect Disord 30:15-26
14. Kessler RC, Walters EE (1998), Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 7:3-14
15. Kim WJ, American Academy of Child and Adolescent Psychiatry Task Force on Workforce Needs (2003), Child and adolescent psychiatry workforce: a critical shortage and national challenge. Acad Psychiatry 27:277-282
16. Kratochvil C, Emslie G, Silva S et al. (2006), Acute time to response in the Treatment for Adolescents With Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 45:1412-1418
17. Leaf P, Alegria M, Cohen P et al. (1996), Mental health service use in the community and schools: results from the four-community MECA study. J Am Acad Child Adolesc Psychiatry 35:889-897
18. March J, Silva S, Petrycki S et al., Treatment for Adolescents With Depression Study (TADS) Team (2004), Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292:807-820
19. March J, Silva S, Vitiello B (2006), The Treatment for Adolescents With Depression Study (TADS): methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry 45:1393-1403
20. Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM (2004), A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 61: 577-584
21. Stein REK, Zitner L, Jensen PS (2006), Interventions for adolescent depression in primary care. Pediatrics 118:1-14
22. Vitiello B, Rohde P, Silva S et al. (2006), Functioning and quality of life in the Treatment for Adolescents With Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 45:1419-1426
23. Zuckerbrot RA, Jensen PS (2006), Improving recognition of adolescent depression in primary care. Arch Pediatr Adolesc Med 160:694-704